•  
  •  
  •  
  •  

2023-03-21 15:33:09

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Zydus granted Orphan Drug Designation by the USFDA for ZYIL1 in treatment of patients with Cryopyrin Associated Periodic Syndrome
  • H G Infra Engineering Ltd receives completion Certificate for the Proiect in the state of Raiasthan
  • NTPC Green Energy Ltd inks pact with Indian Oil Corporation Limited
  • Blue Star forays into the Railway Electrification space, wins four orders worth Rs 575 crores
  • L&T wins Contracts for its Hydrocarbon Business

Keywords Selected:  Assessment

Stock Report

  • Welspun Corp ranks in the Top 7% in Global Steel Industry in S&P Global's DJSI Corporate Sustainability Assessment
  • HCLTech recognized as a Leader in Everest Group's 'IT Security Services PEAK Matrix Assessment 2022 - North America'
  • Mphasis moves up from 69th to 74th percentile in S&P Global's DJSI Corporate Sustainability Assessment Annual Review 2022
  • Adani Ports and Special Economic Zone receives the top ranking in Moody's Global ESG rating
  • BPCL recognized as India's most sustainable Oil and Gas Company in the Dow Jones Sustainability Indices 2022
  • Cyient Reinforces its Position as a Major Contender in Everest's Industry 4.0 Services PEAK Matrix® Assessment 2022
  • Ramco Systems positioned as a LEADER in Everest Group's Multi-Country Payroll Solutions PEAK Matrix® Assessment 2022 for APAC
  • Infosys Positioned as a Leader in IDC MarketScape: Worldwide Intelligent Automation Services 2022 Vendor Assessment
  • Infosys Positioned as a Leader in the IDC MarketScape: Worldwide SAP Implementation Services 2022 Vendor Assessment
  • Alembic Pharmaceuticals completes USFDA RRA for its Bioequivalence Facility
  • Happiest Minds Technologies is positioned as an 'Innovator' in NelsonHall's Digital Banking Services NEAT Report
  • Firstsource Named a Leader by Everest Group in Healthcare Payer Operations PEAK Matrix® Assessment 2022
  • SMS Pharmaceuticals successfully completes remote regulatory assessment by USFDA
  • Aurionpro is now Great Place to Work-Certified™!
  • TCS Named in the IDC MarketScape for Worldwide Retail Price Optimization Solutions
  • Wipro makes its debut as a Leader in IDC's MarketScape: Worldwide Salesforce Implementation Services 2021 Vendor Assessment
  • Tata Power leads S&P Global's ESG Score for Power Utilities in India
  • HCL Technologies Positioned as a Leader in 5G Engineering Services PEAK Matrix® Assessment 2021 by Everest Group
  • Infosys Positioned as a Leader in the IDC MarketScape: Worldwide Managed Multicloud Services 2021 Vendor Assessment
  • Welspun Corp ranked in the Top One-third in the Steel Industry in S&P Global's DJSI Corporate Sustainability Assessment
  • Tata Steel featured amongst the top 10 companies in the steel industry in the DJSI 2021 Assessment
  • IDC MarketScape recognizes Wipro's end-to-end smart manufacturing transformation capabilities
  • Mindtree Named a Major Contender in Everest Group PEAK Matrix® for IoT Supply Chain Solutions
  • JSW Energy achieves Leadership band (A-) in CDP Climate Change 2021

Mutual Funds

  • ESGrisk.ai Launches ESG Mutual Funds Research

Latest Post

  • Zydus granted Orphan Drug Designation by the USFDA for ZYIL1 in treatment of patients with Cryopyrin Associated Periodic Syndrome
  • H G Infra Engineering Ltd receives completion Certificate for the Proiect in the state of Raiasthan
  • NTPC Green Energy Ltd inks pact with Indian Oil Corporation Limited
  • Blue Star forays into the Railway Electrification space, wins four orders worth Rs 575 crores
  • L&T wins Contracts for its Hydrocarbon Business


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
No:AP-172, 2nd Sector, 10th Street, KK Nagar
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

Disclaimer Copyright © - 2022